News | January 21, 2009

New Stretchable Electrodes Created to Study Stresses on Cardiac Cells

January 22, 2008 - Engineers at Purdue and Stanford universities recently created stretchable electrodes to study how cardiac muscle cells, neurons and other cells react to mechanical stresses from heart attacks, traumatic brain injuries and other diseases.

The devices are made by injecting a liquid alloy made of indium and gallium into thin microchannels between two sheets of a plastic polymer, said Babak Ziaie, a Purdue associate professor of electrical and computer engineering.

Cell cultures are grown on top of the new “stretchable cell culture platform.”

“We designed a simple and cost-effective process for fabricating these stretchable platforms,” said Ziaie, who is working with Beth L. Pruitt, an assistant professor of mechanical engineering at Stanford, along with graduate students and other researchers at both universities. “What’s special about this technology is that it allows you to electrically stimulate or monitor the cell population using electrodes while you are applying stress to the cells.”

Stretching the cell cultures causes mechanical stresses like those exerted on tissues during heart attacks and traumatic brain injuries. The researchers have grown mice cardiac muscle cells on the platform and may grow cell cultures of neurons in future work. Cultures of stem cells also could be tested using the system to determine how mechanical stresses prompt the cells to differentiate into specific types of tissues, Ziaie said.

“You cannot stretch solid metal beyond a few percent because it will break, but we’ve been able to stretch these liquid platforms more than 40 percent of their original size,” Ziaie said.

Findings are detailed in a paper being presented Monday, Jan. 26 during the 22nd IEEE International Conference on Micro Electro Mechanical Systems. The conference, sponsored by the Institute of Electrical and Electronics Engineers, will be in Sorrento, Italy.

“We demonstrated that the platform is biocompatible with human aortic muscle cells and mice heart cells,” Ziaie said. “The cells adhered well to the polymer surface during mechanical strain and survived near and on the electrodes after two days of incubation. The platform also maintained its electrical capabilities after being stretched 100 times.”

Purdue researchers designed and fabricated the platform at the Birck Nanotechnology Center in Purdue’s Discovery Park. Stanford researchers grew cardiac muscle cell cultures on the device and tested the platform.

An electronic copy of the research paper is available from Emil Venere at [email protected].


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now